A similar oncogenic role for miR-708 has been observed in chronic lymphocytic leukemia, where its reduced expression affects NF-κB activity via the kinase-β/IKBKB (IKKβ) targeting [6]. The gene discussed is IKBKB; the disease is B-cell chronic lymphocytic leukemia.